Selected article for: "antimalarial chloroquine and hydroxychloroquine antimalarial chloroquine"

Author: Thurston, Scott; Hite, Gary L.; Petry, Alyssa N.; Ray, Sidhartha D.
Title: Chapter 28 Antiprotozoal Drugs
  • Cord-id: sbs9umml
  • Document date: 2015_12_31
  • ID: sbs9umml
    Snippet: Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the July 2013 to December 2014 publications on antiprotozoal drugs covers various antimalarial drugs (4-aminoquinolines chloroquine and hydroxychloroquine, mefloquine, pyrimethamine, proguani
    Document: Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the July 2013 to December 2014 publications on antiprotozoal drugs covers various antimalarial drugs (4-aminoquinolines chloroquine and hydroxychloroquine, mefloquine, pyrimethamine, proguanil hydrochloride and atovaquone, quinine, artesunate, the combination of artesunate+pyronaridine, metronidazole and ornidazole). This review describes changes in the pharmacokinetics of antimalarial drugs, particularly first-line regimens of artemisinin-based compounds, lumefantrine, chloroquine and pyrimethamine+sulphadoxine that occur in pregnancy.

    Search related documents:
    Co phrase search for related documents